Wells Fargo analyst Mike Mayo maintains U.S. Bancorp (NYSE:USB) with a Overweight and lowers the price target from $70 to $60.
IDEXX Laboratories Raises FY2023 EPS Guidance from $9.64-$9.90 to $9.74-$9.90 vs $9.82 Est; Lowers FY2023 Sales Guidance from $3.66B-$3.71B to $3.64B-$3.65B vs $3.68B Est
2023 Growth and Financial Performance Outlook
The Company is updating its full year revenue growth outlook range to 7.9% - 8.4% as reported and 8.3% - 8.8% organically. This updated outlook is centered on the lower end
